MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Parkin deficiency impairs mtDNA dynamics and propagates inflammation

    K. Wasner, S. Smajić, J. Ghelfi, S. Delcambre, C. Prada-Medina, E. Knappe, G. Arena, P. Mulica, G. Agyeah, A. Rakovic, I. Boussaad, K. Badanjak, J. Ohnmacht, J. Gérardy, M. Takanashi, J. Trinh, M. Mittelbronn, N. Hattori, C. Klein, P. Antony, P. Seibler, M. Spielmann, S. Pereira, A. Grünewald (Belvaux, Luxembourg)

    Objective: We sought to explore Parkin’s role in (i) averting neuronal mtDNA dyshomeostasis/release and (ii) the activation of downstream inflammatory processes. Background: Mutations in Parkin…
  • 2022 International Congress

    Clinical and Imaging features of Hyperkinetic Movement Disorders related with Stroke

    H. Valdez Ruvalcaba, H. Martinez, G. Chac Lezama, F. de Leon, H. Pacheco Mendoza, V. Cano Nigenda, L. Alvarez, A. Arauz, A. Medina-Islas (mexico, Mexico)

    Objective: To describe the characteristics of hyperkinetic movement disorders in patients with stroke. Background: Movement disorders (MD) related to cerebrovascular disease represent 22% of all…
  • 2022 International Congress

    Feasibility of artificial intelligence in predicting early phenotype conversion of REM Sleep Behavior Disorder

    L. Lopes, P. Wu, J. Lu, J. Wang, C. Bassetti, A. Rominger, C. Zuo, H. Yu, K. Shi (Bern, Switzerland)

    Objective: The goal of this study was to investigate the feasibility of deep learning in the prediction of disease conversion in RBD patients. Background: Rapid…
  • 2022 International Congress

    A fully immersive virtual reality environment to study gait modulation in Parkinson’s disease

    I. Hanafi, P. Kullmann, IU. Isaias, C. Palmisano (Würzburg, Germany)

    Objective: To investigate the safety and efficacy of a fully immersive virtual reality (VR) paradigm to study gait modulation in subjects with Parkinson’s disease (PD).…
  • 2022 International Congress

    Cholinergic Innervation and Cognitive Functioning in De Novo Parkinson’s Patients with GBA Variations

    S. Slingerland, S. Vander Zee, JM. Boertien, AC. Slomp, T. van Laar (Groningen, Netherlands)

    Objective: To explore the regional cholinergic innervation and clinical characteristics of de novo Parkinson’s disease (PD) patients carrying GBA variants. Background: The most common genetic…
  • 2022 International Congress

    A second level neuropsychological battery for Parkinson’s Disease. Normative data from the Italian population.

    T. Gandolfi, G. Arcara, S. Cuoco, C. Siri, L. Weis, E. Reali, M. Garon, F. Pistonesi, V. Cianci, E. Fiorenzato, G. Santangelo, G. Pezzoli, P. Barone, A. Antonini, R. Biundo (Padova, Italy)

    Objective: The main purpose of this work is to propose modern Italian co-normed data for a battery of ten widely used neuropsychological tests for Parkinsons’…
  • 2022 International Congress

    Studies on stigma in Parkinson’s disease in the world. A literature review

    S. Kibrit, AV. Karacan, G. Kayis, R. Yilmaz, MC. Akbostancı (Ankara, Turkey)

    Objective: To demonstrate the geographical distribution of studies among populations, and to summarize factors associated with stigma in Parkinson’s disease (PD). Background: One of the…
  • 2022 International Congress

    Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Incremental Motor Improvement Observed with Increasing Doses

    S. Isaacson, I. Zhang, E. Pappert, A. Bowling (Boca Raton, USA)

    Objective: Evaluate magnitude of motor improvement with increasing doses of apomorphine sublingual film (SL-APO) in patients with Parkinson’s disease (PD) and OFF episodes. Background: Identifying…
  • 2022 International Congress

    Gene and variant curation of Parkinson’s disease genes by an authoritative expert panel

    J. Beck, K. Lohmann, L. Lange, A. Naito, A. Kumeh, C. Thaxton, M. Weaver, S. Strom, R. Alcalay (New York, USA)

    Objective: Establish an authoritative central curation for causative genes and variants for Parkinson’s disease (PD) Background: The urgency to establish central curation for causative genes…
  • 2022 International Congress

    Changes in gait and mobility measures collected in daily living conditions, in different stages of Parkinson’s disease

    N. Geffen, K. Cohavi, N. Giladi, A. Thaler, R. Alcalay, J. Edgerton, J. Shirvan, J. Cedarbaum, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)

    Objective: To explore mobility measures collected in daily-living conditions in different stages of PD. Background: Gait and mobility impairments are considered a cardinal sign in…
  • « Previous Page
  • 1
  • …
  • 403
  • 404
  • 405
  • 406
  • 407
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley